{"id":4147,"date":"2025-05-08T17:35:29","date_gmt":"2025-05-08T14:35:29","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4147"},"modified":"2025-05-08T17:35:30","modified_gmt":"2025-05-08T14:35:30","slug":"orzaks-gelecegi-ar-ge-ile-insa-ediyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4147","title":{"rendered":"Orzaks Gelece\u011fi Ar-Ge ile \u0130n\u015fa Ediyor"},"content":{"rendered":"\n

T\u00fcrkiye\u2019nin en b\u00fcy\u00fck g\u0131da takviyesi \u00fcretim kapasitelerinden birine sahip olan Orzaks, i\u00e7 pazardaki liderli\u011fini global pazara da ta\u015f\u0131may\u0131 hedefliyor. Orzaks Genel M\u00fcd\u00fcr\u00fc Yunus Emre Alimo\u011flu; \u201c4 milyar TL olan ciromuzu 6.2 milyar TL’ye \u00e7\u0131karma hedefimiz var. Ge\u00e7en y\u0131l 247 milyon TL’lik bir ihracat cirosu ger\u00e7ekle\u015ftirdik. Bu y\u0131l 48\u2019den fazla \u00fclkeye 990 milyon TL’lik bir ihracat cirosu hedefliyoruz.<\/strong> Kazakistan\u2019da kuraca\u011f\u0131m\u0131z yeni fabrikayla \u00fcretim kapasitemizi \u00e7e\u015fitlendirece\u011fiz\u201d dedi.<\/strong><\/p>\n\n\n\n

2004 y\u0131l\u0131nda temelleri at\u0131lan ve bug\u00fcn T\u00fcrkiye\u2019nin en b\u00fcy\u00fck g\u0131da takviyesi \u00fcretim kapasitelerinden birine sahip olan Orzaks, 2025 y\u0131l\u0131na g\u00fc\u00e7l\u00fc hedeflerle giriyor. Orzaks Genel M\u00fcd\u00fcr\u00fc Yunus Emre Alimo\u011flu; \u201cBu y\u0131l ge\u00e7en y\u0131ldan daha b\u00fcy\u00fck bir b\u00fcy\u00fcme hedefi planlad\u0131k. 4 milyar TL olan ciromuzu 6.2 milyar TL’ye \u00e7\u0131karma hedefimiz var. 2020 y\u0131l\u0131ndan beri global pazarlara a\u00e7\u0131lmak \u00fczere \u00e7ok ciddi yat\u0131r\u0131mlar yap\u0131yoruz. 2024 y\u0131l\u0131nda 247 milyon TL’lik bir ihracat cirosu ger\u00e7ekle\u015ftirirken, 2025 y\u0131l\u0131nda ise 48\u2019den fazla \u00fclkeye 990 milyon TL’lik bir ihracat cirosu ger\u00e7ekle\u015ftirmeyi hedefliyoruz\u201d dedi. <\/p>\n\n\n\n

Bilim, kalite ve g\u00fcven temelinde b\u00fcy\u00fcyor<\/strong>

 \u0130stanbul Esenyurt\u2019taki fabrikas\u0131yla ayda ortalama 2.5 milyon kutu \u00fcretim kapasitesine ula\u015fan Orzaks, i\u00e7 pazardaki liderli\u011fini global pazara da ta\u015f\u0131may\u0131 hedefliyor. Amerika, Almanya, \u0130ngiltere, Polonya ve Dubai\u2019de kurdu\u011fu firmalarla dijital sat\u0131\u015f a\u011f\u0131n\u0131 geni\u015fleten Orzaks, Kazakistan\u2019da kuraca\u011f\u0131 yeni fabrikas\u0131yla \u00fcretim kapasitesini co\u011frafi olarak \u00e7e\u015fitlendirecek. Yat\u0131r\u0131mla ilgili konu\u015fan Alimo\u011flu, Kazakistan\u2019daki fabrikan\u0131n 35 Milyon Euro\u2019luk yat\u0131r\u0131m b\u00fcy\u00fckl\u00fc\u011f\u00fcyle kademeli olarak hayata ge\u00e7irilece\u011fini s\u00f6yledi. Alimo\u011flu, bu yat\u0131r\u0131m\u0131n yerel pazarlarda do\u011frudan varl\u0131k stratejisinin bir par\u00e7as\u0131 oldu\u011funu vurgulad\u0131. Alimo\u011flu; \u201cAyr\u0131ca, Sanayi ve Teknoloji Bakanl\u0131\u011f\u0131 taraf\u0131ndan stratejik yat\u0131r\u0131m kapsam\u0131nda desteklenen mikroalg temelli Ar-Ge projelerimizle bitkisel omega-3, protein ve vitamin \u00fcretiminde yeni bir d\u00f6nemi ba\u015flat\u0131yoruz. Toplam 1.2 milyar TL\u2019lik bu ham madde yat\u0131r\u0131m\u0131, Orzaks\u2019\u0131 global ham madde tedarik zincirinin kritik oyuncular\u0131ndan biri yapacak\u201d dedi.<\/p>\n\n\n\n

2018\u2019de probiyotik ham madde \u00fcretim \u00e7al\u0131\u015fmalar\u0131 ba\u015flat\u0131ld\u0131<\/strong>
 <\/strong>
 Kuruldu\u011fu g\u00fcnden bu yana bilimsel yakla\u015f\u0131m\u0131 ve y\u00fcksek kalite standartlar\u0131n\u0131 ilke edinen Orzaks, sekt\u00f6rdeki yerini yaln\u0131zca ticari b\u00fcy\u00fcmeyle de\u011fil, ayn\u0131 zamanda Ar-Ge yat\u0131r\u0131mlar\u0131 ve \u00fcr\u00fcn inovasyonuyla da sa\u011flamla\u015ft\u0131r\u0131yor. Takviye g\u0131da pazar\u0131nda ham madde konusunda da \u00f6nc\u00fc olabilir miyiz d\u00fc\u015f\u00fcncesiyle yola \u00e7\u0131kt\u0131klar\u0131n\u0131 belirten Alimo\u011flu, probiyotik ham madde \u00fcretimine y\u00f6nelik Ar-Ge \u00e7al\u0131\u015fmalar\u0131ndan s\u00f6z etti; \u201cProbiyotik ham maddesinin \u00fcretilmesi \u00fczerine 2018 y\u0131l\u0131nda Ar-Ge \u00e7al\u0131\u015fmalar\u0131 ba\u015flatt\u0131k. T\u00fcrkiye’nin 7 farkl\u0131 co\u011frafi b\u00f6lgesinden, anne s\u00fct\u00fc, inek s\u00fct\u00fc, topraktan ve fermente \u00fcr\u00fcnlerden \u00e7e\u015fitli kaynaklar toplayarak bu \u00fcr\u00fcnlerden probiyotik su\u015flar\u0131 izole ettik. 1000\u2019in \u00fczerinde probiyotik su\u015fu izole ederken, bunlar\u0131n probiyotik \u00f6zelliklerini g\u00f6z \u00f6n\u00fcnde bulundurduk\u201d diye konu\u015ftu.<\/p>\n\n\n\n

\u201cBilimden uzakla\u015fmadan \u00fcretti\u011fimiz \u00fcr\u00fcnler bizi bu g\u00fcnlere getirdi\u201d<\/strong> Orzaks\u2019\u0131n sekt\u00f6rdeki ba\u015far\u0131s\u0131n\u0131 bilimsel ve y\u00fcksek kaliteli \u00fcretime ba\u011flayan Alimo\u011flu \u015fu de\u011ferlendirmelerde bulundu:\u00a0\u201cTakviye \u00fcr\u00fcnleri \u00f6nleyici ve koruyucu sa\u011fl\u0131kta kullan\u0131lan, bazen tedavi edici, bazen tedavi destek olarak \u00fcretilen ve t\u00fcketiciye sunulan \u00fcr\u00fcnler. Bu nedenle takviye edici \u00fcr\u00fcnler form\u00fcl edilirken temiz i\u00e7erikli olarak \u00fcretilmesi, \u00fcr\u00fcn etkile\u015fimlerinin de\u011ferlendirilmesi ve kullan\u0131lan etken maddelerin sa\u011fl\u0131k \u00fczerine olumlu etkilerini bilimsel kaynaklarla ve \u00e7al\u0131\u015fmalarla desteklenmesi\u00a0gerekiyor. Bu do\u011frultuda, yola \u00e7\u0131kt\u0131\u011f\u0131m\u0131z ilk g\u00fcnden beri bilimden uzakla\u015fmadan en y\u00fcksek kalite standartlar\u0131nda \u00fcr\u00fcn \u00fcreterek t\u00fcketiciye sunmam\u0131z ve t\u00fcketicilerin bu \u00fcr\u00fcnlerden olumlu sonu\u00e7lar almalar\u0131 bu g\u00fcnlere gelmemizi sa\u011flad\u0131. Bir taraftan b\u00fcy\u00fcme ihtiyac\u0131m\u0131z do\u011frultusunda \u00fcretim kapasitemizi artt\u0131rmaya devam ederken di\u011fer taraftan da Ar-Ge faaliyetlerimizle i\u015fimizi kolayla\u015ft\u0131rarak yeni \u00fcr\u00fcnler geli\u015ftirmeyi s\u00fcrd\u00fcr\u00fcyoruz.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

T\u00fcrkiye\u2019nin en b\u00fcy\u00fck g\u0131da takviyesi \u00fcretim kapasitelerinden birine sahip olan Orzaks, i\u00e7 pazardaki liderli\u011fini global pazara da ta\u015f\u0131may\u0131 hedefliyor. Orzaks Genel M\u00fcd\u00fcr\u00fc Yunus Emre Alimo\u011flu; \u201c4 milyar TL olan ciromuzu 6.2 milyar TL’ye \u00e7\u0131karma hedefimiz var. Ge\u00e7en y\u0131l 247 milyon TL’lik bir ihracat cirosu ger\u00e7ekle\u015ftirdik. Bu y\u0131l 48\u2019den fazla \u00fclkeye 990 milyon TL’lik bir ihracat cirosu hedefliyoruz. Kazakistan\u2019da kuraca\u011f\u0131m\u0131z yeni fabrikayla \u00fcretim kapasitemizi \u00e7e\u015fitlendirece\u011fiz\u201d dedi.<\/p>\n","protected":false},"author":1,"featured_media":4148,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4147"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4147"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4147\/revisions"}],"predecessor-version":[{"id":4149,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4147\/revisions\/4149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4148"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}